Evelyn Dilsaver acquired $500,000 worth of PACS Group Stock.
Dilsaver is a member of Pacs Group's Board of Directors.
Dilsaver Evelyn S, Director at PACS Group (NYSE:PACS), made an open-market purchase of 16,724 shares on November 24, 2025, for a transaction value of $499,997.43 according to the SEC Form 4 filing.
| Metric | Value |
|---|---|
| Shares traded | 16,724 |
| Transaction value | ~$500,000 |
| Post-transaction shares | 22,739 |
| Post-transaction value (direct ownership) | ~$681,300 |
Transaction value based on SEC Form 4 weighted average purchase price ($29.90); post-transaction value based on Nov. 24, 2025 market close price as reported in source materials.
| Metric | Value |
|---|---|
| Revenue (TTM) | $5.14 billion |
| Net income (TTM) | $167.87 million |
| Dividend yield | N/A |
| 1-year price change | 84.70% |
1-year performance calculated using November 24, 2025 as the reference date.
PACS Group is a large-scale provider of post-acute healthcare services, operating through a network of facilities and professionals across the United States.
Insiders have an endless list of reasons to sell shares but just one reason to buy. The purchase of shares on the open market from Dilsaver suggests the insider expects the company's stock to rise.
Earlier this month, PACS Group announced an amendment and waiver to an outstanding credit agreement. The company expects to use its amended and restated credit facility to fund the potential acquisition of new properties and operations. As of Dec. 1, 2025, the company had about $500 million of available liquidity under a $600 million credit facility.
It's easy to see why Dilsaver is bullish for PACS Group. In 2024, sales rose 31.4% year over year, and the gains haven't subsided. In the first nine months of 2025, revenue rose by 36.4% year over year to reach $3.93 billion. PACS Group also also boasted a relatively high 94.8% occupancy rate at the end of September, which compares well to just 79% for the average competitor in the post acute care industry.
Director: A member of a company's board responsible for overseeing management and major decisions.
Open-market purchase: Buying securities directly on a public exchange, not through private transactions or company-issued grants.
SEC Form 4: A required filing disclosing insider trades by company officers, directors, or large shareholders.
Insider: An individual with access to non-public company information, such as executives or directors.
Direct ownership: Shares held personally by an individual, not through trusts or other entities.
Outstanding shares: The total number of a company's shares currently held by all shareholders.
Weighted average purchase price: The average price paid for shares, weighted by the number of shares bought at each price.
Total return: The investment's price change plus all dividends and distributions, assuming those payouts are reinvested.
Post-acute care: Healthcare services provided after hospitalization, such as rehabilitation or long-term care.
Holding company: A company that owns controlling interests in other companies but does not produce goods or services itself.
Ancillary services: Additional services that support primary healthcare, such as therapy or diagnostic testing.
TTM: The 12-month period ending with the most recent quarterly report.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 981%* — a market-crushing outperformance compared to 194% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of December 8, 2025
Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pacs Group. The Motley Fool has a disclosure policy.